publication venue for
- The prognostic value of sarcopenia in patients with prostate cancer: a systematic review.. 31. 2021
- A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery.. 30. 2020
- An up-to-date catalogue of urinary markers for the management of prostate cancer.. 30. 2020
- Aristolochic acid and its effect on different cancers in uro-oncology.. 30. 2020
- Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy.. 30. 2020
- Smoking and bladder cancer: review of the recent literature.. 30. 2020
- Volume outcome relationship in penile cancer: a systematic review.. 30. 2020
- Ureteral and urethral recurrence after radical cystectomy: a systematic review.. 30. 2020
- Greenlight laser enucleation of the prostate.. 29. 2019
- Viagra: what's all the fuss about?. 8. 1998
- Muscle-invasive transitional cell carcinoma of the bladder: strategies for bladder preservation.. 8. 1998
- New chemotherapy regimens for metastatic bladder cancer.. 8. 1998
- Hypospadias.. 8. 1998
- Bladder cancer: the curious case of a not so rare disease.. 24. 2014
- So you want to be a robotic surgeon?. 23. 2013
- Contemporary issues in varicocele management.. 22. 2012
- Imaging in urology - looking forward.. 18. 2008
- Reconstruction in urology.. 17. 2007
- Secretion of severe acute respiratory syndrome coronavirus 2 in urine. 2020
- Bladder sparing landscape for bacillus Calmette-Guérin unresponsive bladder cancer. 2020
- Bladder-preserving strategies for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected? 2020
- Fibroblast growth factor receptors across urothelial carcinoma landscape. 2020
- Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer. 2020
- Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer. 2020
- The role of taxane-based chemotherapy in the treatment of prostate cancer. 2020
- Where do urologists stand in the era of novel coronavirus-2019 disease. 2020
- Catalog of exogenous risk factors for bladder carcinogenesis. 2020
- Frontiers in combining immune checkpoint inhibitors for advanced urothelial cancer management. 2020
- Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard. 2020
- An update on systemic therapy for penile cancer. 2020
- Burst wave lithotripsy and acoustic manipulation of stones. 2020
- Epigenetic alterations of testicular germ cell tumours. 2020
- Developments in MRI-targeted prostate biopsy. 2020
- En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. 2020
- The changing role of lasers in urologic surgery. 2020
- The landscape of immunotherapy in metastatic urothelial carcinoma. 2019
- Enhanced Recovery after Radical Cystectomy. 2019
- The impact of gender on oncologic outcomes of bladder cancer. 2019
- The interaction of gender and smoking on bladder cancer risks. 2019
- Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice? 2018
- Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice? 2018
- What to do during Bacillus Calmette-Guérin shortage? Valid strategies based on evidence. 2018
- Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients. 2018
- Prostate biopsy: guidelines and evidence. 2018
- The evolving role of percutaneous biopsy in renal masses. 2018
- Robotic assisted simple prostatectomy: recent advances. 2018
- Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature. 2018
- Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review. 2018
- Review of optimal techniques for robotic-assisted radical prostatectomy. 2018
- Metabolic syndrome and voiding dysfunction. 2017
- Partial gland ablation in the management of prostate cancer: a review. 2017
- Immunotherapy for prostate cancer: is prostate an immune responsive tumor? 2016
- Role of salvage lymph node dissection in prostate cancer. 2016
- Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer. 2016
- Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact. 2016
- Update on ablative therapies of renal tumors. 2016
- Molecular subtyping of prostate cancer. 2016
- The treatment of muscle-invasive bladder cancer in geriatric patients. 2016
- GreenLight laser for prostates over 100 ml: what is the evidence? 2016
- Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? 2016
- The role of MRI in active surveillance for men with localized prostate cancer. 2015
- Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy? 2015
- Functional outcomes of partial prostate ablation and focal therapy: are we managing expectations of a bar set too high? 2015
- Kidney-sparing surgery for upper tract urothelial cancer. 2015
- Genomic rearrangements in prostate cancer. 2015
- Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer. 2014
- What is still needed to make focal therapy an accepted segment of standard therapy? 2014
- Does minimally invasive surgery for radical cystectomy provide similar long-term cancer control as open radical surgery? 2013
- Targeted prostate cancer ablation: energy options. 2013
- Anatomic and technical considerations for optimizing recovery of sexual function during robotic-assisted radical prostatectomy. 2013
- Molecular imaging of prostate cancer. 2012
- Metabolic syndrome and sexual dysfunction. 2011
- Standardization and documentation of varicocele evaluation. 2011
- Bladder cancer imaging: an update. 2011
- Oncological outcomes of partial nephrectomy for renal carcinoma greater than 4 cm. 2011
- Male circumcision: Africa and beyond? 2010
- Varicocele repair for treatment of androgen deficiency. 2010
- Factors affecting outcome in renal cell carcinoma. 2010
- Hereditary and familial kidney cancer. 2009
- Critical appraisal of outcomes following open radical prostatectomy. 2009
- Watchful waiting in benign prostatic hyperplasia. 2009
- Adult varicocele. 2008
- Gene therapy in bladder cancer. 2008
- Inventory of prostate cancer predictive tools. 2008
- Advances in positron emission tomography applications for urologic cancers. 2008
- Bladder cancer: can imaging change patient management? 2008
- Current and future imaging for urologic interventions. 2008
- Imaging low-risk prostate cancer. 2008
- The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. 2008
- Open partial nephrectomy: an essential operation with an expanding role. 2007
- Immunologic targeting: how to channel a minimal response for maximal outcome. 2006
- Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer. 2005
- Urethral reconstruction after erosion of slings in women. 2004
- Advances in laparoscopic partial nephrectomy. 2004
- Nonobstructive azoospermia. 2000
- Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer. 2023
- Role of lymphadenectomy during primary surgery for kidney cancer. 2023
- Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023. 2023
- PET in bladder cancer imaging. 2023
- Transperineal vs. transrectal biopsy to reduce postinterventional sepsis. 2023
- Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials. 2023
- En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference? 2023
- Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis. 2022
- Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes. 2022
- Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity? 2022
- Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis. 2022
- Brief update of the new WHO classification for urothelial carcinoma. 2022
- Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder. 2022
- Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. 2022
- Nonmuscle-invasive bladder cancer, old problems, new insights. 2022
- Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. 2022
- En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. 2022
- Are robots the future? A case for robotic pyeloplasty as the gold standard treatment in ureteropelvic junction obstruction. 2022
- Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis. 2022
- Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19. 2021
- Artificial intelligence in prostate histopathology: where are we in 2021? 2021
- COVID-19 crisis and minimally invasive surgery: a narrative review on intraoperative aerosol viral transmission and their impact on guidelines and clinical practice in Austria. 2021
- Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2. 2021
- Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1. 2021
- Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review. 2021
- Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy. 2021
- Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma? 2021
- Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis. 2021
- What is next in second- and later-line treatment of metastatic renal cell carcinoma? review of the recent literature. 2021
- The microbiome in urinary tract infections in children - an update. 2021
- Pathomics in urology. 2020
- The role of imaging in the diagnosis and management of Peyronie's disease. 2020
- The role of leptin and obesity on male infertility. 2020
- Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge. 2020
- Pediatric renal cell carcinoma. 2019
- The role of environmental stress on lower urinary tract symptoms. 2017
- Epidemiology and prevalence of pelvic organ prolapse. 2013
- Total intracorporeal robotic cystectomy: are we there yet? 2013
- Novel targeted therapy for advanced renal carcinoma: trials in progress. 2010
- Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma. 2008
- New treatment approaches in metastatic renal cell carcinoma. 2006
- High-risk metastatic urothelial cancer: chances for cure? 2002
- Second-line treatment of advanced transitional cell carcinoma of the urothelial tract. 2001
- Diagnostic imaging of pelvic floor dysfunction. 2001
- Risks and complications of transrectal ultrasound. 2000